Access to unlicensed medicines for emerging and developing markets
Masters Speciality Access
Masters Speciality Access (MSA), a division of Masters Speciality Pharma, has a successful 30 year track record in supplying high quality, unlicensed medicines to under-served and emerging markets. The ethos behind MSA our belief of always going the extra mile to source and deliver the medicines our customers (health institutions, clinics or hospitals), need, when they need them. This is embodied in our guiding mantra of ‘medicines reaching further’.
Building on the strengths of the company’s legacy, MSA sources medicines to meet specific orders via its established supply chain. It then delivers them to customers (health institutions, clinics or hospitals) quickly, safely and securely, adhering to the highest standards of quality, regulation and pharmacovigilance and supported by a stringent audit trail. Our aim is to supply medicines as cost effectively as possible and we encourage customers to engage with us at the earliest opportunity so that this can be achieved with maximum efficiency.
An unrivalled global network
MSA has an unrivalled network of customers and partners which means that we deliver medicines effectively and efficiently. With strong financial backing and long standing partnerships with pharmaceutical and hospitals we can fulfil unmet customer need in Southern and Central America, the Caribbean and the Middle East and even markets that are hard to reach.
We are also keen to explore additional partnerships with pharmaceutical and distribution companies to help us to reach even more customers.